Abstract
The purpose of this study is to investigate the risk factors and susceptibilities to antifungal agents of Candida albicans and Candida non-albicans species (spp.) in candidemia cases in Kobe University Hospital. We investigated all consecutive patients with candida bloodstream infection (BSI) from 2008–2013 for whose full data were available for analyses, examining clinical factors such as gender, general complications, postoperative status or susceptibilities to antifungal agents. These factors were also compared between Candida albicans spp. and Candida non-albicans by univariate and multivariate analyses. Univariate analyses showed a significantly higher rate of Candida non-albicans species BSI patients cancer (odds ratio (OR) (95% confidence interval (CI))=2.29 (1.04–5.06) and P=0.040), chemotherapy (OR=4.35 (1.11–17.1) and P=0.035), fluconazole (FLCZ) resistance (OR=77.3 (4.51–1324) and P=0.003), and itraconazole (ITCZ) resistance (OR=15.6 (5.39–45.1) and P<0.001) and lower rate of underlying cardiovascular diseases (OR=0.27 (0.09–0.80) and P=0.018) and postoperative status (OR=0.35 (0.16–0.77) and P=0.035) in than Candida albicans. Multivariate analyses demonstrated that Candida non-albicans spp. had significantly higher rate of chemotherapy (OR=4.44 (1.04–19.0) and P=0.045), FLCZ resistance (OR=5.87 (2.01–17.1) and P=0.001), and ITCZ resistance (OR=18.7(5.77–60.4) and P<0.001) and lower rate of underlying cardiovascular diseases (OR=0.25 (0.08–0.82) and P=0.022) than Candida albicans. In conclusion, this study revealed several risk factors for BSI with Candida albicans (underlying cardiovascular diseases and postoperative status) and Candida non-albicans spp. (cancer and chemotherapy), and demonstrated that Candida non-albicans spp. were more resistant to FLCZ and ITCZ than Candida albicans.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Bukhary, Z. A. Candiduria: a review of clinical significance and management. Saudi J. Kidney Dis. Transpl. 19, 350–360 (2008).
Wise, G. J. & Silver, D. A. Fungal infections of the genitourinary system. J. Urol. 149, 1377–1388 (1993).
Wainstein, M. A., Graham, R. C. Jr & Resnick, M. I. Predisposing factors of systemic fungal infections of the genitourinary tract. J. Urol. 154, 160–163 (1995).
Reagan, D. R., Pfaller, M. A., Hollis, R. J. & Wenzel, R. P. Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe. J. Clin. Microbiol. 28, 2733–2738 (1990).
Toya, S. P., Schraufnagel, D. E. & Tzelepis, G. E. Candiduria in intensive care units: association with heavy colonization and candidaemia. J. Hosp. Infect. 66, 201–206 (2007).
Clark, T. A. et al. Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital. J. Clin. Microbiol. 42, 4468–4472 (2004).
Ostrosky-Zeichner, L. & Pappas, P. G. Invasive candidiasis in the intensive care unit. Crit. Care Med. 34, 857–863 (2006).
Beck-Sague, C. & Jarvis, W. R. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. National Nosocomial Infections Surveillance System. J. Infect. Dis. 167, 1247–1251 (1993).
Krcmery, V. & Barnes, A. J. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J. Hosp. Infect. 50, 243–260 (2002).
Ma, C. F. et al. Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China. BMC Infect. Dis. 13, 337 (2013).
Lerolle, N. et al. Increased intensity of treatment and decreased mortality in elderly patients in an intensive care unit over a decade. Crit. Care Med. 38, 59–64 (2010).
Halpern, N. A. & Pastores, S. M. Critical care medicine in the United States 2000–2005: an analysis of bed numbers, occupancy rates, payer mix, and costs. Crit. Care Med. 38, 65–71 (2010).
Giri, S. & Kindo, A. J. A review of Candida species causing bloodstream infection. Indian J. Med. Microbiol. 30, 270–278 (2012).
Ha, Y. E. et al. Impact of first-line antifungal agents on the outcomes and costs of candidemia. Antimicrob. Agents Chemother. 56, 3950–3956 (2012).
Ostrosky-Zeichner, L., Lashof, A. O., Kullberg, B. J. & Rex, J. H. Voriconazole salvage treatment of invasive candidiasis. Eur. J. Clin. Microbiol. Infect. Dis. 22, 651–655 (2003).
Peman, J., Canton, E. & Gobernado, M., Spanish ECMM Working Group on Candidaemia Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain. Eur. J. Clin. Microbiol. Infect. Dis. 24, 23–30 (2005).
Muñoz, P. et al. Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital. J. Antimicrob. Chemother. 55, 188–193 (2005).
Chow, J. K. et al. Risk factors for albicans and non-albicans candidemia in the intensive care unit. Crit. Care Med. 36, 1993–1938 (2008).
Chow, J. K. et al. Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. Clin. Infect. Dis. 46, 1206–1213 (2008).
Pfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B. & Wenzel, R. P. Surveillance and Control of Pathogens of Epidemiologic. Diagn. Microbiol. Infect. Dis. 30, 121–129 (1998).
Kao, A. S. et al. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin. Infect. Dis. 29, 1164–1170 (1999).
Baran, J. Jr, Muckatira, B. & Khatib, R. Candidemia before and during the fluconazole era: prevalence, type of species and approach to treatment in a tertiary care community hospital. Scand. J. Infect. Dis. 33, 137–139 (2001).
Abi-Said, D. et al. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin. Infect. Dis. 24, 1122–1128 (1997).
Trick, W. E. et al. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989–1999. Clin. Infect. Dis. 35, 627–630 (2002).
Pappas, P. G. et al. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin. Infect. Dis. 37, 634–643 (2003).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shigemura, K., Osawa, K., Jikimoto, T. et al. Comparison of the clinical risk factors between Candida albicans and Candida non-albicans species for bloodstream infection. J Antibiot 67, 311–314 (2014). https://doi.org/10.1038/ja.2013.141
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ja.2013.141
Keywords
This article is cited by
-
Species distribution and susceptibility profiles of oral candidiasis in hematological malignancy and solid tumor patients
Brazilian Journal of Microbiology (2023)
